ARWR: First-in-class dual gene knockdown, strong triglyceride reduction, and expanding innovative pipeline

ARO-DIMER-PA achieved first-in-class dual gene knockdown with strong early efficacy and safety, while plozasiran's launch in FCS exceeded expectations and demonstrated robust triglyceride reduction and safety. The pipeline advances in CNS and obesity, leveraging AI and proprietary RNAi expertise, p…